AKTS Aktis Oncology, Inc.
Healthcare$20.34+6.38%ClosedMarket Cap: $1.09B
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
2.22
P/S
180.14
EV/EBITDA
-13.47
DCF Value
$2.39
FCF Yield
-5.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
89.2%
Operating Margin
-924.0%
Net Margin
-754.9%
ROE
-130.3%
ROA
-7.9%
ROIC
-10.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $3.2M | 79.8% | $-22.7M | $-18.3M | $— | — |
| Q4 null | $1.9M | 100.0% | $-17.4M | $-15.1M | $— | — |
| FY null | $6.5M | 100.0% | $-74.7M | $-63.7M | $— | — |
| Q4 null | $933.0K | 100.0% | $-15.6M | $-12.1M | $— | — |
| FY null | $1.5M | 100.0% | $-52.0M | $-44.0M | $— | — |
| FY null | $0.00 | NaN% | $-34.8M | $-28.6M | $— | — |
| FY null | $0.00 | NaN% | $-19.8M | $-17.9M | $— | — |